Cite
HARVARD Citation
Sekiguchi, N. et al. (2020). A multicenter, open‐label, phase II study of tirabrutinib (ONO/GS‐4059) in patients with Waldenström's macroglobulinemia. Cancer science. 111 (9), pp. 3327-3337. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Sekiguchi, N. et al. (2020). A multicenter, open‐label, phase II study of tirabrutinib (ONO/GS‐4059) in patients with Waldenström's macroglobulinemia. Cancer science. 111 (9), pp. 3327-3337. [Online].